Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?

Journal of Gastroenterology

Volumn 35, Issue 2, 2000, Pages 79-86

  Kitano, Seigo ^a   Dolgor, Baatar ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Gastric ulcer; Liver cirrhosis; Portal hypertension

Indexed keywords

ALCOHOL; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NITRIC OXIDE; PEPSIN A; PROPRANOLOL; PROSTAGLANDIN; RANITIDINE;

CLINICAL TRIAL; ENZYME RELEASE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; LIVER CIRRHOSIS; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH ACID; STOMACH BLOOD FLOW; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH ULCER; ULCER HEALING;

EID: 0034014191     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050018     Document Type: Review

References (85)

1. Langman MJ, Cooke AR. Gastric and duodenal ulcer and their associated diseases. Lancet 1976;I:680-3.
2. Thiel H. Hepatogenic ulcer: theories and facts (review). Z Gastroenterol 1978;16:73-84.
3. Lanza FL, Davis RE. Asymptomatic ulcers and erosions occur in normal volunteer populations (abstract). Am J Gastroenterol 1984;79:43.
4. Akdamar K, Ertan A, Agrawal NM, McMahon FG, Ryan J. Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc 1986;32:78-80.
5. Tomoda J, Mizuno M, Sugihara T, Itano T, Tsuji T. Gastric mucosal lesion in liver disease: impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis. J Gastroenterol Hepatol 1989;4(Suppl 1 ):136-9.
6. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996;11:59-64.
7. Siringo S, Burroughs AK, Bolondi L, Muia A, Di Feho G, Miglioli M. et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995;22:633-41.
8. Bonnevie O. The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol 1975;10:231-9.
9. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995;42:424-7.
10. Tsai CJ. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 1998;43:1219-25.
11. Graham DY. Campylobacter pylori and peptic ulcer disease (review). Gastroenterology 1989;96(Suppl):615-25.
12. McCormick PA, Sankey EA, Cardin F, Dhillon AP, McIntyre N, Burroughs AK. Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut 1991;32:351-4.
13. D'Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spano C. et al. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 1990;99:1558-64.
14. Bhargava N, Venkateswaran S, Ramakrishna BS, Mathan M. Colonization by Helicobacter pylori and its relationship to histological changes in the gastric mucosa in portal hypertension. J Gastroenterol Hepatol 1994;9:507-11.
15. Wang CH, Ma LR, Lin RC, Kuo JY, Chang KK. Helicobacter pylori infection and risk of peptic ulcer among cirrhotic patients. J Formos Med Assoc 1997;96:55-8.
16. Fraser AG, Pounder RE, Burroughs AK. Gastric secretion and peptic ulceration in cirrhosis. J Hepatol 1993;19:171-82.
17. Savarino V, Mela GS, Zentilin P, Mansi C, Mele MR, Vigneri S, et al. Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. J Hepatol 1996;25:152-7.
18. Gaur SK, Vij JC, Sarin SK, Anand BS. Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis. Digestion 1988;39:151-5.
19. Pique JM, Leung FW, Kitahora T, Sarfeh IJ, Tarnawski A, Guth PH. Gastric mucosal blood flow and acid secretion in portal hypertensive rats. Gastroenterology 1988;95:727-33.
20. Agnihotri N, Kaur S, Dilawari JB, Bhusnurmath SR, Kaur U. Diminution in parietal cell number in experimental portal hypertensive gastropathy. Dig Dis Sci 1997;42:431-9.
21. Agnihotri N, Kaur U, Dhawan V, Dilawari JB. Extrahepatic portal hypertensive gastropathy in Wistar rats: modulation of acid secretion in isolated parietal cells. Dig Dis Sci 1998;43:56-66.
22. Ostrow JD, Timmerman RJ, Gray SJ, Gastric secretion in human hepatic cirrhosis. Gastroenterology 1960;38:303-13.
23. Sato T, Imamura M, Sasaki I, Ohneda A. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients. Am J Gastroenterol 1985;80:163-9.
24. Lo WC, Lin HJ, Wang K, Lee FY, Perng CL, Lin HC, et al. Gastric secretion in Chinese patients with cirrhosis. J Clin Gastroenterol 1996;23:256-60.
25. Mitsunaga A, Yokoyama S, Hashimoto H, Hirose H, Adachi H, Kurokawa K, et al. Clinical study of the aggressive factors of the gastric mucosa in liver cirrhosis. J Gastroenterol Hepatol 1989; 4(Suppl 1):266-7.
26. Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Elena M, et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 1987;93:1054-61.
27. Perez-Ayuso RM, Pique JM, Saperas E, Bombi JA, Bordas JM, Elena M. et al. Gastric vascular ectasias in cirrhosis: association with hypoacidity not related to gastric atrophy. Scand J Gastroenterol 1989;24:1073-8.
28. Sarfeh IJ, Tamawski A, Malki A, Mason GR, Mach T, Ivey KJ. Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Gastroenterology 1983;84:987-93.
29. Sarfeh IJ, Tamawski A, Macda R, Raymont K, Mason GR, Ivey KJ. The gastric mucosa in portal hypertension: effects of topical bile acid. Scand J Gastroenterol Suppl 1984;92:189-94.
30. Sarfeh IJ, Tamawski A, Hajduczek A, Stachura J, Bui HX, Krause WJ. The portal hypertensive gastric mucosa: histologic, ultrastructural and functional analysis after aspirin-induced damage. Surgery 1988;104:79-85.
31. Payen JL, Cales P, Pienkowski P, Sozzani P, Kervran A, Frexinos J, et al. Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil. J Hepatol 1995;23:689-96.
32. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defense (review). FASEB J 1996;10:731-40.
33. Hashizume M, Tanaka K, Inokuchi K. Morphology of gastric microcirculation in cirrhosis. Hepatology 1983;3:1008-12.
34. Tarnawski AS, Sarfeh IJ, Stachura J, Hajduczek A, Bui HX, Dabros W, et al. Microvascular abnormalities of the portal hypertensive gastric mucosa. Hepatology 1988;8:1488-94.
35. Sarfeh IJ, Soliman H, Waxman K, Coccia M, Rypins EB, Bui HX, et al. Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 1989;34:225-8.
36. Casadevall M, Tabasco-Minguillan J, Panes J, Cirera I, Pique JM, Teres J. Time-course changes in gastric mucosal blood perfusion following portal vein constriction in rats. J Hepatol 1995;23:193-8.
37. Kitano S, Inokuchi K, Sugimachi K, Koyanagi N. Hemodynamic and morphological changes in the stomach of portal hypertensive rats. Eur Surg Res 1981;13:227-35.
38. Benoil JN, Womack WA, Korthuis RJ, Wilborn WH, Granger DN. Chronic portal hypertension: effects on gastrointestinal blood flow distribution. Am J Physiol 1986;250:G535-9.
39. Panes J, Bordas JM, Pique JM, Bosch J, Garcia-Pagan JC, Feu F, et al. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992;103: 1875-82.
40. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Harada H, et al. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy. Hepatology 1993;18:36-40.
41. Toyonaga A, Iwao T, Portal-hypertensive gastropathy (review). J Gastroenterol Hepatol 1998;13:865-77.
42. Holzer P, Livingston EH, Sana A, Guth PH. Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol 1991;260:0363-70.
43. Buck PL, Lee SS, McKnight GW, Wallace JL. Characterization of spontaneous and ethanol-induced gastric damage in cirrhotic rats. Gastroenterology 1992;103:1048-55.
44. Nishizaki Y, Guth PH, Sternini C, Kaunitz JD. Impairment of the gastric hyperemic response to luminal acid in cirrhotic rats. Am J Physiol 1996;270:G71-8.
45. Ferraz JG, McKnight W, Sharkey KA, Wallace JL. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. Gastroenterology 1995;108:1183-91.
46. Nishizaki Y, Kaunitz JD, Oda M, Guth PH. Impairment of gastric mucosal defenses measured in vivo in cirrhotic rats. Hepatology 1944;20:445-52.
47. Tanoue K, Tarnawski AS, Kishihara F, Ohta M, Hashizume M, Sugimachi K. et al. Effect of teprenone on portal hypertensive gastric mucosa. Digestion 1996;57:35-40.
48. Wang JY, Hsieh JS, Huang TJ. Changes in rat gastric mucosal glycoproteins in portal hypertension. Eur Surg Res 1997;29:280-6.
49. Ninomiya K, Kitano S, Yoshida T, Bandoh T, Baatar D, Tsuboi S. Impaired adaptive cytoprotection to ethanol-induced damage in gastric mucosa of portal hypertensive rats. Dig Dis Sci 1999; 44:1254-60.
50. Sakai M, Sagara K, Fujiyama S, Murata H, Sato T. Gastric mucosal hexosamine content in various liver diseases. Hepatogastrocnterology 1991;38:302-6.
51. Iwao T, Toyonaga A, Ikegami M, Shigemori H, Oho K, Sumino M, et al. Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone. Dig Dis Sci 1996; 41:1727-32.
52. Eastwood GL. Epithelial renewal in protection and repair of gastroduodenal mucosa (review). J Clin Gastroenterol 1991; 13(Suppl 1):S48-53.
53. Hsieh JS, Huang TJ. The effect of portal hypertension on gastric epithelial proliferation in rats. Eur Surg Res 1993;25:98-103.
54. Baatar D, Kitano S, Yoshida T, Bandoh T, Ninomiya K, Tsuboi S. The role of nitric oxide in the inhibition of epithelial proliferation in portal hypertensive rats. J Hepatol 1999;30:1099-104.
55. Whittle BJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990;99:607-11.
56. Arakawa T, Satoh H, Fukuda T, Nakamura H, Kobayashi K. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology 1987;93:135-40.
57. Weiler H, Weiler C, Gerok W. Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension. J Hepatol 1990;11:58-64.
58. Saperas E, Perez Ayuso RM, Poca E, Bordas JM, Gaya J, Pique JM. Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia. Am J Gastroenterol 1990; 85:138-44.
59. Ohta M, Kishihara F, Hashizume M, Kawanaka H, Tomikawa M, Higashi H. Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy. Prostaglandins Leukot Essent Fatty Acids 1995;53:41-5.
60. Arakawa T, Tarnawski A, Mach T, Kobayashi K, Sarfeh IJ. Impaired generation of prostaglandins from isolated gastric surface epithelial cells in portal hypertensive rats. Prostaglandins 1990;40: 373-82.
61. Beck PL, McKnight W, Lee SS, Wallace JL. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. Am J Physiol 1993;265:G453-8.
62. Geraldo J, Ferraz P, Wallace JL. Prostaglandins modulate the responsiveness of the gastric microcirculation of sodium nitroprusside in cirrhotic rats. Hepatology 1996;23:123-9.
63. Ohta M, Tanouc K, Tarnawski AS, Pai R, Itani RM, Sander FC, et al. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology 1997;112:1920-30.
64. El-Newihi HM, Kanji VK, Mihas AA. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroentcrol 1996;91:535-8.
65. Uchihara M, Izumi N, Sato C, Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992;16:95-9.
66. Asbert M, Gines A, Gines P, Jimenez W, Claria J, Salo J, et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993;104:1485-91.
67. Whittle BJ, Esplugues JV. Induction of rat gastric damage by the endothelium-derived peptide, endothelin. Br J Pharmacol 1988; 95:1011-3.
68. Lazaratos S, Kashimura H, Nakahara A, Fukutomi H, Osuga T, Urushidani T, et al. Gastric ulcer induced by submucosal injection of ET-1: role of potent vasoconstriction and intraluminal acid. Am J Physiol 1993;265:G491-8.
69. Ohta M, Nguyen TH, Tarnawski AS, Pai R, Kratzberg YP, Sugimachi K, et al. Overexpression of endothelin-1 mRNA and protein in portal hypertensive gastric mucosa of rats: a key to increased susceptibility to damage? Surgery 1997;122:936-42.
70. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26: 1226-32.
71. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995; 108:761-7.
72. Ohta M, Tarnawski AS, Itani R, Pai R, Tomikawa M, Sugimachi K, et al. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats. Hepatology 1998;27:906-13.
73. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996;270: G42-8.
74. Beyaert R, Fiers W. Molecular mechanisms of tumor necrosis factor-induced cytoloxicity. What we do understand and what we do not (review). FEBS Lett 1994;340:9-16.
75. Ferraz JG, Tigley AW, Appleyard CB, Wallace JL. TNF-alpha contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats. Am J Physiol 1997;272:G809-14.
76. Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
77. Di Mario F, Gottardello L, Germana B, Dotto P, Grassi S, Vianello F, et al. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol 1992;24:122-5.
78. Walker S, Krishna DR, Klotz U, Bode JC. Frequent non-response to histamine H2-receptor antagonists in cirrhotics. Gut 1989;30:1105-9.
79. Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990;336:840-3.
80. Schmassmann A, Tarnawski A, Peskar BM, Varga L, Flogerzi B, Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995;268:G276-85.
81. Ichikawa Y, Tarnawski A, Sarfeh IJ, Ishikawa T, Shimada H. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats. Gastroenterology 1994;106:702-8.
82. Baatar D, Kitano S, Yoshida T, Bandoh T, Ninomiya K, Tsuboi S. Delayed healing of acetic acid-induced gastric ulcer in portal hypertensive rats. Eur Surg Res 1999;31:340-6.
83. Sankary H, Sarfeh IJ, Tarnawski A, Maeda R, Ivey KJ, Mason GR. Propranolol reduces ethanol-induced gastric mucosal damage in portal hypertensive rats. Dig Dis Sci 1986;31:162-5.
84. Geoffroy P, Duchateau A, Thiefin G, Zeitoun P. Effects of propranolol and sucralfate on ethanol-induced gastric mucosal damage in chronic portal hypertensive rats. J Hepatol 1987;5:162-6.
85. Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987;7:437-41.